Montorsi F, Guazzoni G, Barbieri L, Ferini-Strambi L, Iannaccone S, Calori G, Nava L, Rigatti P, Pizzini G, Miani A
Department of Neurology, University of Milan School of Medicine, Italy.
J Urol. 1998 Jan;159(1):113-5. doi: 10.1016/s0022-5347(01)64029-1.
We assessed whether re-dosing of a vasoactive agent or the combination of a vasoactive injection and genital plus audiovisual sexual stimulation caused the greatest erectile effect to determine which of the 2 procedures would be better for dynamic penile color Doppler sonography in patients with erectile dysfunction.
A total of 20 consecutive patients with erectile dysfunction underwent 2 sessions under real-time RigiScan* recording of penile erection. Session 1 consisted of adaptation in 10 minutes, intracavernous injection of 10 micrograms. alprostadil in 10 minutes and re-dosing of 10 micrograms. alprostadil in 10 minutes. Session 2 consisted of adaptation in 10 minutes, injection of 10 micrograms. alprostadil in 10 minutes and genital plus audiovisual sexual stimulation in 10 minutes. The total duration of each session was 30 minutes. The order of the 2 sessions was randomly assigned with a week interval between each session.
Re-dosing and genital plus audiovisual sexual stimulation caused a significant increase in erectile response compared to the result seen after the first injection (re-dosing p < 0.05, injection plus stimulation p < 0.01). However, erectile response after the genital stimulation session was significantly greater than that after re-dosing (p < 0.01). An erection comparable to the greatest spontaneous erection reported by the patient was much more frequently achieved after genital stimulation than after the re-dosing session (p < 0.01).
The combination of injection and stimulation caused a significantly greater erectile response than re-dosing. We suggest that the former should always be used during color Doppler sonography to optimize the accuracy of the test. Re-dosing is suggested when an incomplete erectile response occurs after the injection plus stimulation phase.
我们评估了血管活性药物的再次给药或血管活性注射与生殖器及视听性刺激相结合是否能产生最大的勃起效果,以确定这两种方法中哪一种对勃起功能障碍患者的动态阴茎彩色多普勒超声检查效果更好。
连续20例勃起功能障碍患者在阴茎勃起的实时RigiScan*记录下接受了2次检查。第1次检查包括10分钟的适应期、10分钟内海绵体内注射10微克前列地尔,以及10分钟内再次注射10微克前列地尔。第2次检查包括10分钟的适应期、10分钟内注射10微克前列地尔以及10分钟的生殖器及视听性刺激。每次检查的总时长为30分钟。两次检查的顺序随机分配,每次检查间隔一周。
与首次注射后的结果相比,再次给药以及生殖器及视听性刺激均使勃起反应显著增加(再次给药p<0.05,注射加刺激p<0.01)。然而,生殖器刺激检查后的勃起反应显著大于再次给药后的反应(p<0.01)。与患者报告的最大自发勃起相当的勃起,在生殖器刺激后比再次给药检查后更频繁地实现(p<0.01)。
注射与刺激相结合引起的勃起反应明显大于再次给药。我们建议在彩色多普勒超声检查期间应始终使用前者以优化检查的准确性。当注射加刺激阶段后出现不完全勃起反应时,建议再次给药。